Mechanisms of Antimicrobial Resistance

Mechanisms of Antimicrobial Resistance

Mechanisms of Antimicrobial Resistance

On this page

Mechanisms of Antimicrobial Resistance: AMR Fundamentals - Resistance Rising

AMR: Microbe's ability to withstand antimicrobial drugs, previously effective for treatment.

  • Intrinsic Resistance: Natural, inherent to the organism; predictable.
    • E.g., Gram-negative bacteria resistant to Penicillin G (due to outer membrane impermeability).
  • Acquired Resistance: Microbe obtains the ability to resist a drug to which it was previously susceptible.
    • E.g., MRSA (Methicillin-Resistant Staphylococcus aureus) due to acquisition of the mecA gene.
  • Genetic Basis (Acquired):
    • Mutations: Spontaneous changes in bacterial DNA.
    • Horizontal Gene Transfer (HGT): Transfer of resistance genes between bacteria. 📌 Can Transfer Too (Conjugation, Transduction, Transformation).
      • Conjugation: Gene transfer via direct cell-to-cell contact (e.g., plasmids).
      • Transduction: Gene transfer via bacteriophages (viruses infecting bacteria).
      • Transformation: Uptake of naked DNA from the environment.
    • Mobile Genetic Elements (MGEs): DNA segments that can move within or between genomes (e.g., plasmids, transposons, integrons).

Mechanisms of Antimicrobial Resistance

⭐ Vancomycin resistance in Staphylococcus aureus (VRSA) often arises from acquiring the vanA gene cluster from vancomycin-resistant enterococci (VRE) via conjugation on a plasmid. This is a critical example of HGT leading to high-level resistance against a last-resort antibiotic.

Mechanisms of Antimicrobial Resistance: Target Tampering - The Altered Lock

Bacteria alter drug target sites, reducing binding. "Altered Lock, Key Won't Fit."

  • PBP Modification:
    • MRSA: mecA gene → PBP2a (low β-lactam affinity).
    • S. pneumoniae: Altered PBPs (penicillin resistance).
  • Ribosomal Alteration:
    • Macrolides: Methylation of 23S rRNA (erm genes). (📌 ERM = Erythromycin Ribosomal Methylase)
    • Aminoglycosides: 16S rRNA mutations.
    • Linezolid: 23S rRNA (domain V) mutations.
  • DNA Gyrase/Topoisomerase IV Alteration:
    • Fluoroquinolones: Mutations in gyrA, gyrB (DNA gyrase) or parC, parE (topoisomerase IV).
  • Cell Wall Precursor Alteration:
    • Vancomycin: $D-Ala-D-Ala \rightarrow D-Ala-D-Lac$ (vanA gene cluster) or $D-Ala-D-Ser$ (vanB, vanC genes).

⭐ The mecA gene product, PBP2a, confers resistance to virtually all β-lactam antibiotics.

Mechanisms of Antimicrobial Resistance: Drug Defense - Destroy & Discard

Bacteria neutralize antibiotics by: enzymatic destruction or active removal.

  • Enzymatic Inactivation/Modification (Destroy)

    • β-Lactamases: Hydrolyze β-lactam ring. Major classes:
      ClassExamplesKey Feature
      AESBLs, KPCSerine; clavulanate-inhibited (ESBLs)
      BNDM-1, VIMMetallo ($Zn^{2+}$); broad spectrum
      CAmpCSerine; cephalosporinase; inducible
      DOXASerine; hydrolyzes oxacillin/carbapenems
    • Aminoglycoside-Modifying Enzymes:
      • Acetyltransferases (AAC)
      • Phosphotransferases (APH)
      • Nucleotidyltransferases (ANT)
    • Chloramphenicol Acetyltransferase (CAT): Acetylates chloramphenicol.
  • Decreased Drug Accumulation (Discard via Efflux Pumps)

    • Actively pump out antibiotics.
    • Tetracycline-specific: Tet(A), Tet(K) pumps.
    • Multi-Drug Resistance (MDR) Pumps:
      • ABC (ATP-Binding Cassette) superfamily
      • MFS (Major Facilitator Superfamily)
      • RND (Resistance-Nodulation-Division) family (e.g., AcrAB-TolC in E. coli)
      • 📌 Mnemonic for MDR pumps: "All My Resistance": ABC, MFS, RND.

Mechanisms of Antimicrobial Resistance

⭐ Carbapenemases like NDM-1 confer resistance to nearly all β-lactams, including carbapenems, and are often plasmid-mediated.

Mechanisms of Antimicrobial Resistance: Entry Denied & Bypassed - The Great Escape

  • 1. Decreased Permeability/Uptake (Entry Blocked)

    • Gram-negatives: Porin loss/mutation in outer membrane ↓ drug entry (e.g., β-lactams, FQs, aminoglycosides).
      • E. coli: OmpF, OmpC mutations.
      • P. aeruginosa: OprD loss (↓ carbapenem, esp. imipenem, entry).
    • Porin mutations reducing antibiotic entry into Gram-negative
  • 2. Alternative Metabolic Pathways (Target Bypassed)

    • Bacteria develop new pathways, rendering drug ineffective.
    • Examples:
      • Sulfonamides: Altered dihydropteroate synthase (DHPS) or ↑ PABA.
      • Trimethoprim: Altered dihydrofolate reductase (DHFR).

⭐ Loss of OprD porin in Pseudomonas aeruginosa is a key mechanism of imipenem resistance. Meropenem may be less affected due to alternative entry routes.

High‑Yield Points - ⚡ Biggest Takeaways

  • Enzymatic degradation: β-lactamases (e.g., ESBLs, KPCs) inactivate penicillins & cephalosporins.
  • Target modification: Altered PBPs (MRSA), ribosomal methylation (macrolides, clindamycin), gyrase mutations (quinolones).
  • Reduced permeability: Porin channel loss limits entry of drugs like carbapenems.
  • Efflux pumps: Multi-drug resistance (MDR) pumps actively expel antibiotics (e.g., tetracyclines, fluoroquinolones).
  • Target bypass/protection: VanA/VanB genes in VRE alter peptidoglycan precursor, reducing vancomycin binding.
  • Biofilm formation provides a protective niche and facilitates horizontal gene transfer, increasing resistance spread.

Practice Questions: Mechanisms of Antimicrobial Resistance

Test your understanding with these related questions

Which antimicrobial resistance mechanism is most commonly associated with extended-spectrum cephalosporin resistance in Neisseria gonorrhoeae?

1 of 5

Flashcards: Mechanisms of Antimicrobial Resistance

1/9

_____ is the molecular basis of penicillin G resistance in pneumococci and meningococci.

TAP TO REVEAL ANSWER

_____ is the molecular basis of penicillin G resistance in pneumococci and meningococci.

Transformation

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial